News | TCTAP & AP VALVES 2020 Virtual

Post-TAVR Anti-thrombotics: Issues Unresolved

August 7th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

August 08, 2020 14710 0 Read More

News | TCTAP & AP VALVES 2020 Virtual

Redevelopment and Validation of the SYNTAX score II 2020

Individualized Decision Making between Percutaneous and Surgical Revascularization in Patients with Complex Coronary Artery Disease

August 08, 2020 191192 0 Read More

News | TCTAP & AP VALVES 2020 Virtual

10-Year Final Report of PRECOMBAT Trial: Keeping up with the debate of PCI vs. CABG in LM

August 7th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

August 08, 2020 23721 0 Read More

News | TCTAP & AP VALVES 2020 Virtual

East-Asian Paradox for Antithrombotics: Theory, Evidence and Next Strategy

August 6th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

August 07, 2020 9266 0 Read More

News | TCTAP & AP VALVES 2020 Virtual

P2Y12 Inhibitor Monotherapy: Updated Evidence and Clinical Implication in Real-World

August 6th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

August 07, 2020 49605 0 Read More

News | TCTAP & AP VALVES 2020 Virtual

The DEFINE-FLOW Study: Combined CFR and FFR Lesion Assessment

August 6th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

August 07, 2020 12851 0 Read More

News | TCTAP & AP VALVES 2020 Virtual

Imaging-guided PSP: How to Optimize Your Stent for Complex Coronary Lesions?

August 6th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

August 07, 2020 87974 0 Read More